UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ANAB — Anaptysbio, Inc
CIK 861177
NEW YORK, NY
Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,573,425
-$130,692 QoQ
Shares Held
23,310
-49.4% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 211 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ANAB ranks #108 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ANAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,573,425 | 23,310 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,704,117 | 30,727 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,479,026 | 30,508 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,018,756 | 33,271 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,105,669 | 49,805 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $649,030 | 34,913 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $390,303 | 29,479 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,101,608 | 32,884 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $743,306 | 29,661 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $381,060 | 16,921 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $362,447 | 16,921 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $303,900 | 16,921 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $344,173 | 16,921 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $368,201 | 16,921 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $586,909 | 23,007 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $297,313 | 14,646 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $569,191 | 23,007 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $799,493 | 23,007 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $659,394 | 24,314 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $630,461 | 24,314 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $315,622 | 14,646 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $362,768 | 16,873 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $248,875 | 16,873 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $376,941 | 16,873 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $202,751 | 14,349 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||